首页 > 最新文献

Journal of Zhejiang University. Science. B最新文献

英文 中文
AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer. AAZ2通过靶向PDK1诱导线粒体依赖性胃癌细胞凋亡。
Pub Date : 2023-03-15 DOI: 10.1631/jzus.B2200351
Yi Li, Wenyan She, Xiaoran Xu, Yixin Liu, Xinyu Wang, Sheng Tian, Shiyi Li, Miao Wang, Chaochao Yu, Pan Liu, Tianhe Huang, Yongchang Wei

Drastic surges in intracellular reactive oxygen species (ROS) induce cell apoptosis, while most chemotherapy drugs lead to the accumulation of ROS. Here, we constructed an organic compound, arsenical N-‍(4-(1,3,2-dithiarsinan-2-yl)phenyl)acrylamide (AAZ2), which could prompt the ROS to trigger mitochondrial-dependent apoptosis in gastric cancer (GC). Mechanistically, by targeting pyruvate dehydrogenase kinase 1 (PDK1), AAZ2 caused metabolism alteration and the imbalance of redox homeostasis, followed by the inhibition of phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway and leading to the activation of B-cell lymphoma 2 (Bcl2)/Bcl2-associated X (Bax)/caspase-9 (Cas9)/Cas3 cascades. Importantly, our in vivo data demonstrated that AAZ2 could inhibit the growth of GC xenograft. Overall, our data suggested that AAZ2 could contribute to metabolic abnormalities, leading to mitochondrial-dependent apoptosis by targeting PDK1 in GC.

细胞内活性氧(ROS)的急剧增加会诱导细胞凋亡,而大多数化疗药物会导致ROS的积累。在此,我们构建了一个有机化合物,砷N-‍(4-(1,3,2-二硫胂酸-2-基)苯基)丙烯酰胺(AAZ2),它可以促进ROS触发胃癌(GC)线粒体依赖性凋亡。机制上,AAZ2通过靶向丙酮酸脱氢酶激酶1 (PDK1),引起代谢改变和氧化还原稳态失衡,进而抑制磷酸肌醇-3激酶(PI3K)/蛋白激酶B (AKT)/哺乳动物雷帕霉素靶蛋白(mTOR)通路,激活B细胞淋巴瘤2 (Bcl2)/Bcl2相关X (Bax)/caspase-9 (Cas9)/Cas3级联反应。重要的是,我们的体内数据表明,AAZ2可以抑制GC异种移植物的生长。总之,我们的数据表明,AAZ2可能通过靶向GC中的PDK1导致代谢异常,导致线粒体依赖性凋亡。
{"title":"AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer.","authors":"Yi Li,&nbsp;Wenyan She,&nbsp;Xiaoran Xu,&nbsp;Yixin Liu,&nbsp;Xinyu Wang,&nbsp;Sheng Tian,&nbsp;Shiyi Li,&nbsp;Miao Wang,&nbsp;Chaochao Yu,&nbsp;Pan Liu,&nbsp;Tianhe Huang,&nbsp;Yongchang Wei","doi":"10.1631/jzus.B2200351","DOIUrl":"https://doi.org/10.1631/jzus.B2200351","url":null,"abstract":"<p><p>Drastic surges in intracellular reactive oxygen species (ROS) induce cell apoptosis, while most chemotherapy drugs lead to the accumulation of ROS. Here, we constructed an organic compound, arsenical <i>N</i>-‍(4-(1,3,2-dithiarsinan-2-yl)phenyl)acrylamide (AAZ2), which could prompt the ROS to trigger mitochondrial-dependent apoptosis in gastric cancer (GC). Mechanistically, by targeting pyruvate dehydrogenase kinase 1 (PDK1), AAZ2 caused metabolism alteration and the imbalance of redox homeostasis, followed by the inhibition of phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway and leading to the activation of B-cell lymphoma 2 (Bcl2)/Bcl2-associated X (Bax)/caspase-9 (Cas9)/Cas3 cascades. Importantly, our in vivo data demonstrated that AAZ2 could inhibit the growth of GC xenograft. Overall, our data suggested that AAZ2 could contribute to metabolic abnormalities, leading to mitochondrial-dependent apoptosis by targeting PDK1 in GC.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"232-247"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014317/pdf/JZhejiangUnivSciB-24-3-232.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma. 雌激素通过PI3K-AKT通路上调子宫内膜癌中DNA2的表达。
Pub Date : 2023-03-15 DOI: 10.1631/jzus.B2200436
Xinyan Wang, Xiuling Xu, Ting Zhang, Yang Jin, Sheng Xu, Lifeng Chen, Yucheng Lai, Ling Zhang, Ruolang Pan, Yan Yu

Endometrial cancer is the most common gynecological malignancy, affecting up to 3% of women at some point during their lifetime (Morice et al., 2016; Li and Wang, 2021). Based on the pathogenesis and biological behavioral characteristics, endometrial cancer can be divided into estrogen-dependent (I) and non-estrogen-dependent (II) types (Ulrich, 2011). Type I accounts for approximately 80% of cases, of which the majority are endometrioid carcinomas, and the remaining are mucinous adenocarcinomas (Setiawan et al., 2013). It is generally recognized that long-term stimulation by high estrogen levels with the lack of progesterone antagonism is the most important risk factor; meanwhile, there is no definite conclusion on the specific pathogenesis. The incidence of endometrial cancer has been on the rise during the past two decades (Constantine et al., 2019; Gao et al., 2022; Luo et al., 2022). Moreover, the development of assisted reproductive technology and antiprogestin therapy following breast cancer surgery has elevated the risk of developing type I endometrial cancer to a certain extent (Vassard et al., 2019). Therefore, investigating the influence of estrogen in type I endometrial cancer may provide novel concepts for risk assessment and adjuvant therapy, and at the same time, provide a basis for research on new drugs to treat endometrial cancer.

子宫内膜癌是最常见的妇科恶性肿瘤,高达3%的女性在其一生中的某个阶段受到影响(Morice等人,2016;Li and Wang, 2021)。根据发病机制和生物学行为特征,子宫内膜癌可分为雌激素依赖型(estrogen-dependent, I)和非雌激素依赖型(non-estrogen-dependent, II) (Ulrich, 2011)。I型约占80%,其中以子宫内膜样癌居多,其余为粘液腺癌(Setiawan et al., 2013)。人们普遍认为,长期高雌激素水平刺激和缺乏孕酮拮抗作用是最重要的危险因素;同时,具体的发病机制尚无明确的结论。在过去二十年中,子宫内膜癌的发病率一直在上升(Constantine等人,2019;Gao et al., 2022;Luo et al., 2022)。此外,辅助生殖技术的发展和乳腺癌手术后抗黄体酮治疗在一定程度上提高了患I型子宫内膜癌的风险(Vassard et al., 2019)。因此,研究雌激素在I型子宫内膜癌中的影响,可能为风险评估和辅助治疗提供新的思路,同时为研究治疗子宫内膜癌的新药提供依据。
{"title":"Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma.","authors":"Xinyan Wang,&nbsp;Xiuling Xu,&nbsp;Ting Zhang,&nbsp;Yang Jin,&nbsp;Sheng Xu,&nbsp;Lifeng Chen,&nbsp;Yucheng Lai,&nbsp;Ling Zhang,&nbsp;Ruolang Pan,&nbsp;Yan Yu","doi":"10.1631/jzus.B2200436","DOIUrl":"https://doi.org/10.1631/jzus.B2200436","url":null,"abstract":"<p><p>Endometrial cancer is the most common gynecological malignancy, affecting up to 3% of women at some point during their lifetime (Morice et al., 2016; Li and Wang, 2021). Based on the pathogenesis and biological behavioral characteristics, endometrial cancer can be divided into estrogen-dependent (I) and non-estrogen-dependent (II) types (Ulrich, 2011). Type I accounts for approximately 80% of cases, of which the majority are endometrioid carcinomas, and the remaining are mucinous adenocarcinomas (Setiawan et al., 2013). It is generally recognized that long-term stimulation by high estrogen levels with the lack of progesterone antagonism is the most important risk factor; meanwhile, there is no definite conclusion on the specific pathogenesis. The incidence of endometrial cancer has been on the rise during the past two decades (Constantine et al., 2019; Gao et al., 2022; Luo et al., 2022). Moreover, the development of assisted reproductive technology and antiprogestin therapy following breast cancer surgery has elevated the risk of developing type I endometrial cancer to a certain extent (Vassard et al., 2019). Therefore, investigating the influence of estrogen in type I endometrial cancer may provide novel concepts for risk assessment and adjuvant therapy, and at the same time, provide a basis for research on new drugs to treat endometrial cancer.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"262-268"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014318/pdf/JZhejiangUnivSciB-24-3-262.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An epipolythiodioxopiperazine alkaloid and diversified aromatic polyketides with cytotoxicity from the Beibu Gulf coral-derived fungus Emericella nidulans GXIMD 02509. 北部湾珊瑚源真菌美刺藻GXIMD 02509中具有细胞毒性的外聚硫代二氧哌嗪生物碱和多种芳香聚酮。
Pub Date : 2023-03-15 DOI: 10.1631/jzus.B2200622
Miaoping Lin, Zhenzhou Tang, Jiaxi Wang, Humu Lu, Chenwei Wang, Yanting Zhang, Xinming Liu, Chenghai Gao, Yonghong Liu, Xiaowei Luo
北部湾藴育着丰富且亟待研究的海洋(微)生物资源,是活性天然产物的重要来源。本研究从涠洲岛珊瑚共附生构巢裸胞壳菌GXIMD 02509中分离获得一个多硫代二酮哌嗪生物碱和系列芳香聚酮类化合物,包含一个新化合物4a- O -methoxyarugosin H ( 1 )。我们通过采用多种波、光谱学技术及对比文献方法鉴定了化合物的化学结构。化合物 1 ∼ 5 、7和 10 对786-O、SW1990和SW480等3株肿瘤细胞增殖具抑制活性,半抑制浓度(IC_50)值为4.3∼33.4 µmol/L。化合物emestrin J ( 10 )具有一个二硫桥键,还能够显著抑制786-O细胞克隆及迁移,诱导786-O细胞凋亡并阻滞细胞分裂在G2/M期,是一个潜在具抗肿瘤活性的先导化合物。
海洋微生物,特别是海洋真菌,历史上已经证明了它们作为结构新颖和具有药理活性的次级代谢物的丰富来源的价值(Deshmukh等人,2018;Carroll et al., 2022)。珊瑚是生物多样性最高的珊瑚礁的主体,其组织层、骨骼层和黏液层中蕴藏着高度多样化和丰富的微生物共生体,其特定物种的核心成员在空间上划分在珊瑚微栖息地之间(王wq等,2022)。最近发现与珊瑚相关的真菌是结构多样的化合物、萜烯、生物碱、多肽、芳烃、内酯和类固醇的重要生产者。它们具有广泛的生物活性,如抗癌、抗菌和防污活性(Chen et al., 2022)。遗传强大的Emericella属(子囊菌门),有海洋和陆地来源,包括30多种,分布在世界各地。它被认为是具有抗菌活性或细胞毒性的多种次级代谢物的丰富来源(Alburae等,2020)。值得注意的是,最近有报道称,典型生物合成菌株假曲霉(Aspergillus nidulans)的性状态为高度甲基化的聚酮(Li et al., 2019)和含有异吲哚酮的meroterpenoids (Zhou et al., 2016)的重要来源,其骨架异常。
{"title":"An epipolythiodioxopiperazine alkaloid and diversified aromatic polyketides with cytotoxicity from the Beibu Gulf coral-derived fungus <i>Emericella nidulans</i> GXIMD 02509.","authors":"Miaoping Lin,&nbsp;Zhenzhou Tang,&nbsp;Jiaxi Wang,&nbsp;Humu Lu,&nbsp;Chenwei Wang,&nbsp;Yanting Zhang,&nbsp;Xinming Liu,&nbsp;Chenghai Gao,&nbsp;Yonghong Liu,&nbsp;Xiaowei Luo","doi":"10.1631/jzus.B2200622","DOIUrl":"https://doi.org/10.1631/jzus.B2200622","url":null,"abstract":"北部湾藴育着丰富且亟待研究的海洋(微)生物资源,是活性天然产物的重要来源。本研究从涠洲岛珊瑚共附生构巢裸胞壳菌GXIMD 02509中分离获得一个多硫代二酮哌嗪生物碱和系列芳香聚酮类化合物,包含一个新化合物4a- O -methoxyarugosin H ( 1 )。我们通过采用多种波、光谱学技术及对比文献方法鉴定了化合物的化学结构。化合物 1 ∼ 5 、7和 10 对786-O、SW1990和SW480等3株肿瘤细胞增殖具抑制活性,半抑制浓度(IC_50)值为4.3∼33.4 µmol/L。化合物emestrin J ( 10 )具有一个二硫桥键,还能够显著抑制786-O细胞克隆及迁移,诱导786-O细胞凋亡并阻滞细胞分裂在G2/M期,是一个潜在具抗肿瘤活性的先导化合物。","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"275-280"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014321/pdf/JZhejiangUnivSciB-24-3-275.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Aerobic glycolysis in colon cancer is repressed by naringin via the HIF1Α pathway. 柚皮苷通过HIF1Α途径抑制结肠癌的有氧糖酵解。
Pub Date : 2023-03-15 DOI: 10.1631/jzus.B2200221
Guangtao Pan, Ping Zhang, Aiying Chen, Yu Deng, Zhen Zhang, Han Lu, Aoxun Zhu, Cong Zhou, Yanran Wu, Sen Li

Metabolic reprogramming is a common phenomenon in cancer, with aerobic glycolysis being one of its important characteristics. Hypoxia-inducible factor-1α (HIF1Α) is thought to play an important role in aerobic glycolysis. Meanwhile, naringin is a natural flavanone glycoside derived from grapefruits and many other citrus fruits. In this work, we identified glycolytic genes related to HIF1Α by analyzing the colon cancer database. The analysis of extracellular acidification rate and cell function verified the regulatory effects of HIF1Α overexpression on glycolysis, and the proliferation and migration of colon cancer cells. Moreover, naringin was used as an inhibitor of colon cancer cells to illustrate its effect on HIF1Α function. The results showed that the HIF1Α and enolase 2 (ENO2) levels in colon cancer tissues were highly correlated, and their high expression indicated a poor prognosis for colon cancer patients. Mechanistically, HIF1Α directly binds to the DNA promoter region and upregulates the transcription of ENO2; ectopic expression of ENO2 increased aerobic glycolysis in colon cancer cells. Most importantly, we found that the appropriate concentration of naringin inhibited the transcriptional activity of HIF1Α, which in turn decreased aerobic glycolysis in colon cancer cells. Generally, naringin reduces glycolysis in colon cancer cells by reducing the transcriptional activity of HIF1Α and the proliferation and invasion of colon cancer cells. This study helps to elucidate the relationship between colon cancer progression and glucose metabolism, and demonstrates the efficacy of naringin in the treatment of colon cancer.

代谢重编程是癌症中的常见现象,有氧糖酵解是其重要特征之一。缺氧诱导因子-1α (HIF1Α)被认为在有氧糖酵解中起重要作用。同时,柚皮苷是一种天然的黄酮苷,从葡萄柚和许多其他柑橘类水果中提取。在这项工作中,我们通过分析结肠癌数据库确定了与HIF1Α相关的糖酵解基因。细胞外酸化速率和细胞功能分析验证了HIF1Α过表达对糖酵解、结肠癌细胞增殖和迁移的调节作用。此外,柚皮苷被用作结肠癌细胞的抑制剂,以说明其对HIF1Α功能的影响。结果显示HIF1Α与结肠癌组织中烯醇化酶2 (ENO2)水平高度相关,其高表达预示着结肠癌患者预后较差。在机制上,HIF1Α直接与DNA启动子区结合,上调ENO2的转录;异位表达ENO2可增加结肠癌细胞的有氧糖酵解。最重要的是,我们发现适当浓度的柚皮苷可以抑制HIF1Α的转录活性,从而降低结肠癌细胞的有氧糖酵解。一般来说,柚皮苷通过降低HIF1Α的转录活性和结肠癌细胞的增殖和侵袭来减少结肠癌细胞中的糖酵解。本研究有助于阐明结肠癌进展与糖代谢的关系,并证实柚皮苷对结肠癌的治疗作用。
{"title":"Aerobic glycolysis in colon cancer is repressed by naringin via the <i>HIF1Α</i> pathway.","authors":"Guangtao Pan,&nbsp;Ping Zhang,&nbsp;Aiying Chen,&nbsp;Yu Deng,&nbsp;Zhen Zhang,&nbsp;Han Lu,&nbsp;Aoxun Zhu,&nbsp;Cong Zhou,&nbsp;Yanran Wu,&nbsp;Sen Li","doi":"10.1631/jzus.B2200221","DOIUrl":"https://doi.org/10.1631/jzus.B2200221","url":null,"abstract":"<p><p>Metabolic reprogramming is a common phenomenon in cancer, with aerobic glycolysis being one of its important characteristics. Hypoxia-inducible factor-1α (<i>HIF1Α</i>) is thought to play an important role in aerobic glycolysis. Meanwhile, naringin is a natural flavanone glycoside derived from grapefruits and many other citrus fruits. In this work, we identified glycolytic genes related to <i>HIF1Α</i> by analyzing the colon cancer database. The analysis of extracellular acidification rate and cell function verified the regulatory effects of <i>HIF1Α</i> overexpression on glycolysis, and the proliferation and migration of colon cancer cells. Moreover, naringin was used as an inhibitor of colon cancer cells to illustrate its effect on <i>HIF1Α</i> function. The results showed that the <i>HIF1Α</i> and enolase 2 (<i>ENO2</i>) levels in colon cancer tissues were highly correlated, and their high expression indicated a poor prognosis for colon cancer patients. Mechanistically, <i>HIF1Α</i> directly binds to the DNA promoter region and upregulates the transcription of <i>ENO2</i>; ectopic expression of <i>ENO2</i> increased aerobic glycolysis in colon cancer cells. Most importantly, we found that the appropriate concentration of naringin inhibited the transcriptional activity of <i>HIF1Α</i>, which in turn decreased aerobic glycolysis in colon cancer cells. Generally, naringin reduces glycolysis in colon cancer cells by reducing the transcriptional activity of <i>HIF1Α</i> and the proliferation and invasion of colon cancer cells. This study helps to elucidate the relationship between colon cancer progression and glucose metabolism, and demonstrates the efficacy of naringin in the treatment of colon cancer.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"221-231"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014316/pdf/JZhejiangUnivSciB-24-3-221.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9119361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway. 双硫仑通过抑制范可尼贫血修复通路增强顺铂的抗肿瘤活性。
Pub Date : 2023-03-15 DOI: 10.1631/jzus.B2200405
Meng Yuan, Qian Wu, Mingyang Zhang, Minshan Lai, Wenbo Chen, Jianfeng Yang, Li Jiang, Ji Cao

A series of chemotherapeutic drugs that induce DNA damage, such as cisplatin (DDP), are standard clinical treatments for ovarian cancer, testicular cancer, and other diseases that lack effective targeted drug therapy. Drug resistance is one of the main factors limiting their application. Sensitizers can overcome the drug resistance of tumor cells, thereby enhancing the antitumor activity of chemotherapeutic drugs. In this study, we aimed to identify marketable drugs that could be potential chemotherapy sensitizers and explore the underlying mechanisms. We found that the alcohol withdrawal drug disulfiram (DSF) could significantly enhance the antitumor activity of DDP. JC-1 staining, propidium iodide (PI) staining, and western blotting confirmed that the combination of DSF and DDP could enhance the apoptosis of tumor cells. Subsequent RNA sequencing combined with Gene Set Enrichment Analysis (GSEA) pathway enrichment analysis and cell biology studies such as immunofluorescence suggested an underlying mechanism: DSF makes cells more vulnerable to DNA damage by inhibiting the Fanconi anemia (FA) repair pathway, exerting a sensitizing effect to DNA damaging agents including platinum chemotherapy drugs. Thus, our study illustrated the potential mechanism of action of DSF in enhancing the antitumor effect of DDP. This might provide an effective and safe solution for combating DDP resistance in clinical treatment.

一系列诱导DNA损伤的化疗药物,如顺铂(DDP),是卵巢癌、睾丸癌等缺乏有效靶向药物治疗的疾病的标准临床治疗方法。耐药是限制其应用的主要因素之一。增敏剂可以克服肿瘤细胞的耐药性,从而增强化疗药物的抗肿瘤活性。在这项研究中,我们旨在确定可能成为潜在化疗致敏剂的上市药物并探索其潜在机制。我们发现酒精戒断药双硫仑(DSF)能显著增强DDP的抗肿瘤活性。JC-1染色、碘化丙啶(PI)染色、western blotting均证实DSF与DDP联合使用可促进肿瘤细胞凋亡。随后的RNA测序结合基因集富集分析(Gene Set Enrichment Analysis, GSEA)通路富集分析和免疫荧光等细胞生物学研究提示其潜在机制:DSF通过抑制Fanconi贫血(FA)修复通路,使细胞更容易受到DNA损伤,对铂类化疗药物等DNA损伤剂产生增敏作用。因此,我们的研究阐明了DSF增强DDP抗肿瘤作用的潜在作用机制。这可能为临床治疗抗DDP耐药提供一种有效、安全的解决方案。
{"title":"Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.","authors":"Meng Yuan,&nbsp;Qian Wu,&nbsp;Mingyang Zhang,&nbsp;Minshan Lai,&nbsp;Wenbo Chen,&nbsp;Jianfeng Yang,&nbsp;Li Jiang,&nbsp;Ji Cao","doi":"10.1631/jzus.B2200405","DOIUrl":"https://doi.org/10.1631/jzus.B2200405","url":null,"abstract":"<p><p>A series of chemotherapeutic drugs that induce DNA damage, such as cisplatin (DDP), are standard clinical treatments for ovarian cancer, testicular cancer, and other diseases that lack effective targeted drug therapy. Drug resistance is one of the main factors limiting their application. Sensitizers can overcome the drug resistance of tumor cells, thereby enhancing the antitumor activity of chemotherapeutic drugs. In this study, we aimed to identify marketable drugs that could be potential chemotherapy sensitizers and explore the underlying mechanisms. We found that the alcohol withdrawal drug disulfiram (DSF) could significantly enhance the antitumor activity of DDP. JC-1 staining, propidium iodide (PI) staining, and western blotting confirmed that the combination of DSF and DDP could enhance the apoptosis of tumor cells. Subsequent RNA sequencing combined with Gene Set Enrichment Analysis (GSEA) pathway enrichment analysis and cell biology studies such as immunofluorescence suggested an underlying mechanism: DSF makes cells more vulnerable to DNA damage by inhibiting the Fanconi anemia (FA) repair pathway, exerting a sensitizing effect to DNA damaging agents including platinum chemotherapy drugs. Thus, our study illustrated the potential mechanism of action of DSF in enhancing the antitumor effect of DDP. This might provide an effective and safe solution for combating DDP resistance in clinical treatment.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 3","pages":"207-220"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014319/pdf/JZhejiangUnivSciB-24-3-207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society. 《多粘菌素B治疗药物监测中国共识指南》,由上海市医学会感染与化疗专业委员会和中国药理学学会治疗药物监测专业委员会批准。
Pub Date : 2023-02-15 DOI: 10.1631/jzus.B2200466
Xiaofen Liu, Chenrong Huang, Phillip J Bergen, Jian Li, Jingjing Zhang, Yijian Chen, Yongchuan Chen, Beining Guo, Fupin Hu, Jinfang Hu, Linlin Hu, Xin Li, Hongqiang Qiu, Hua Shao, Tongwen Sun, Yu Wang, Ping Xu, Jing Yang, Yong Yang, Zhenwei Yu, Bikui Zhang, Huaijun Zhu, Xiaocong Zuo, Yi Zhang, Liyan Miao, Jing Zhang

Polymyxin B, which is a last-line antibiotic for extensively drug-resistant Gram-negative bacterial infections, became available in China in Dec. 2017. As dose adjustments are based solely on clinical experience of risk toxicity, treatment failure, and emergence of resistance, there is an urgent clinical need to perform therapeutic drug monitoring (TDM) to optimize the use of polymyxin B. It is thus necessary to standardize operating procedures to ensure the accuracy of TDM and provide evidence for their rational use. We report a consensus on TDM guidelines for polymyxin B, as endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society. The consensus panel was composed of clinicians, pharmacists, and microbiologists from different provinces in China and Australia who made recommendations regarding target concentrations, sample collection, reporting, and explanation of TDM results. The guidelines provide the first-ever consensus on conducting TDM of polymyxin B, and are intended to guide optimal clinical use.

多粘菌素B是治疗广泛耐药革兰氏阴性细菌感染的最后一线抗生素,于2017年12月在中国上市。由于剂量调整仅基于临床对风险毒性、治疗失败、出现耐药的经验,临床迫切需要开展治疗性药物监测(TDM)以优化多粘菌素b的使用,因此有必要规范操作程序,以确保TDM的准确性,并为其合理使用提供依据。我们报告了上海医学会感染与化疗专业委员会和中国药理学学会治疗药物监测专业委员会对多粘菌素B TDM指南的共识。共识小组由来自中国和澳大利亚不同省份的临床医生、药剂师和微生物学家组成,他们就靶浓度、样本收集、报告和TDM结果的解释提出了建议。该指南首次就多粘菌素B进行TDM达成共识,旨在指导最佳临床应用。
{"title":"Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society.","authors":"Xiaofen Liu,&nbsp;Chenrong Huang,&nbsp;Phillip J Bergen,&nbsp;Jian Li,&nbsp;Jingjing Zhang,&nbsp;Yijian Chen,&nbsp;Yongchuan Chen,&nbsp;Beining Guo,&nbsp;Fupin Hu,&nbsp;Jinfang Hu,&nbsp;Linlin Hu,&nbsp;Xin Li,&nbsp;Hongqiang Qiu,&nbsp;Hua Shao,&nbsp;Tongwen Sun,&nbsp;Yu Wang,&nbsp;Ping Xu,&nbsp;Jing Yang,&nbsp;Yong Yang,&nbsp;Zhenwei Yu,&nbsp;Bikui Zhang,&nbsp;Huaijun Zhu,&nbsp;Xiaocong Zuo,&nbsp;Yi Zhang,&nbsp;Liyan Miao,&nbsp;Jing Zhang","doi":"10.1631/jzus.B2200466","DOIUrl":"https://doi.org/10.1631/jzus.B2200466","url":null,"abstract":"<p><p>Polymyxin B, which is a last-line antibiotic for extensively drug-resistant Gram-negative bacterial infections, became available in China in Dec. 2017. As dose adjustments are based solely on clinical experience of risk toxicity, treatment failure, and emergence of resistance, there is an urgent clinical need to perform therapeutic drug monitoring (TDM) to optimize the use of polymyxin B. It is thus necessary to standardize operating procedures to ensure the accuracy of TDM and provide evidence for their rational use. We report a consensus on TDM guidelines for polymyxin B, as endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society. The consensus panel was composed of clinicians, pharmacists, and microbiologists from different provinces in China and Australia who made recommendations regarding target concentrations, sample collection, reporting, and explanation of TDM results. The guidelines provide the first-ever consensus on conducting TDM of polymyxin B, and are intended to guide optimal clinical use.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"130-142"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260281/pdf/JZhejiangUnivSciB-24-2-130.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Multiple characteristic alterations and available therapeutic strategies of cellular senescence. 细胞衰老的多种特征改变和可用的治疗策略。
Pub Date : 2023-02-15 DOI: 10.1631/jzus.B2200178
Yunzi Zhao, Hui Li, Qinglong Guo, Hui Hui

Given its state of stable proliferative inhibition, cellular senescence is primarily depicted as a critical mechanism by which organisms delay the progression of carcinogenesis. Cells undergoing senescence are often associated with the alteration of a series of specific features and functions, such as metabolic shifts, stemness induction, and microenvironment remodeling. However, recent research has revealed more complexity associated with senescence, including adverse effects on both physiological and pathological processes. How organisms evade these harmful consequences and survive has become an urgent research issue. Several therapeutic strategies targeting senescence, including senolytics, senomorphics, immunotherapy, and function restoration, have achieved initial success in certain scenarios. In this review, we describe in detail the characteristic changes associated with cellular senescence and summarize currently available countermeasures.

鉴于其稳定的增殖抑制状态,细胞衰老主要被描述为生物体延缓癌变进程的关键机制。细胞衰老通常与一系列特定特征和功能的改变有关,如代谢变化、干性诱导和微环境重塑。然而,最近的研究揭示了衰老的复杂性,包括对生理和病理过程的不利影响。生物如何逃避这些有害后果并生存已成为一个迫切的研究问题。针对衰老的几种治疗策略,包括抗衰老药、senomorphics、免疫疗法和功能恢复,在某些情况下已经取得了初步的成功。在这篇综述中,我们详细描述了与细胞衰老相关的特征变化,并总结了目前可用的对策。
{"title":"Multiple characteristic alterations and available therapeutic strategies of cellular senescence.","authors":"Yunzi Zhao,&nbsp;Hui Li,&nbsp;Qinglong Guo,&nbsp;Hui Hui","doi":"10.1631/jzus.B2200178","DOIUrl":"https://doi.org/10.1631/jzus.B2200178","url":null,"abstract":"<p><p>Given its state of stable proliferative inhibition, cellular senescence is primarily depicted as a critical mechanism by which organisms delay the progression of carcinogenesis. Cells undergoing senescence are often associated with the alteration of a series of specific features and functions, such as metabolic shifts, stemness induction, and microenvironment remodeling. However, recent research has revealed more complexity associated with senescence, including adverse effects on both physiological and pathological processes. How organisms evade these harmful consequences and survive has become an urgent research issue. Several therapeutic strategies targeting senescence, including senolytics, senomorphics, immunotherapy, and function restoration, have achieved initial success in certain scenarios. In this review, we describe in detail the characteristic changes associated with cellular senescence and summarize currently available countermeasures.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"101-114"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9615425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model. 在lps诱导的小鼠脓毒症模型中,连辛碱减轻脾脏组织的炎症和氧化应激。
Pub Date : 2023-02-15 DOI: 10.1631/jzus.B2200340
Hanyu Wang, Yuanhao Yang, Xiao Zhang, Yan Wang, Hui Fan, Jinfeng Shi, Xuelian Tan, Baoshi Xu, Jingchao Qiang, Enzhuang Pan, Mingyi Chu, Zibo Dong, Jingquan Dong

Sepsis is a complex syndrome caused by multiple pathogens and involves multiple organ failure, particularly spleen dysfunction. In 2017, the worldwide incidence was 48.9 million sepsis cases and 11 million sepsis-related deaths were reported (Rudd et al., 2020). Inflammation, oxidative stress, and apoptosis are the most common pathologies seen in sepsis. Liensinine (LIE) is a bisbenzylisoquinoline-type alkaloid extracted from the seed embryo of Nelumbo nucifera. Lotus seed hearts have high content of LIE which mainly has antihypertensive and antiarrhythmic pharmacological effects. It can exert anti-carcinogenic activity by regulating cell, inflammation, and apoptosis signaling pathways (Manogaran et al., 2019). However, its protective effect from sepsis-induced spleen damage is unknown. In this research, we established a mouse sepsis model induced by lipopolysaccharide (LPS) and investigated the protective effects of LIE on sepsis spleen injury in terms of inflammatory response, oxidative stress, and apoptosis.

脓毒症是一种由多种病原体引起的复杂综合征,涉及多器官功能衰竭,尤其是脾功能障碍。2017年,全球脓毒症发病率为4890万例,报告了1100万例脓毒症相关死亡(Rudd et al., 2020)。炎症、氧化应激和细胞凋亡是脓毒症最常见的病理。莲子碱是一种从莲子胚中提取的双苄基异喹啉类生物碱。莲子心含有高含量的LIE,主要具有抗高血压和抗心律失常的药理作用。它可以通过调节细胞、炎症和凋亡信号通路发挥抗癌活性(Manogaran et al., 2019)。然而,其对败血症引起的脾损伤的保护作用尚不清楚。本研究通过建立脂多糖(LPS)诱导的小鼠脓毒症模型,从炎症反应、氧化应激、细胞凋亡等方面研究LIE对脓毒症脾损伤的保护作用。
{"title":"Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model.","authors":"Hanyu Wang,&nbsp;Yuanhao Yang,&nbsp;Xiao Zhang,&nbsp;Yan Wang,&nbsp;Hui Fan,&nbsp;Jinfeng Shi,&nbsp;Xuelian Tan,&nbsp;Baoshi Xu,&nbsp;Jingchao Qiang,&nbsp;Enzhuang Pan,&nbsp;Mingyi Chu,&nbsp;Zibo Dong,&nbsp;Jingquan Dong","doi":"10.1631/jzus.B2200340","DOIUrl":"https://doi.org/10.1631/jzus.B2200340","url":null,"abstract":"<p><p>Sepsis is a complex syndrome caused by multiple pathogens and involves multiple organ failure, particularly spleen dysfunction. In 2017, the worldwide incidence was 48.9 million sepsis cases and 11 million sepsis-related deaths were reported (Rudd et al., 2020). Inflammation, oxidative stress, and apoptosis are the most common pathologies seen in sepsis. Liensinine (LIE) is a bisbenzylisoquinoline-type alkaloid extracted from the seed embryo of Nelumbo nucifera. Lotus seed hearts have high content of LIE which mainly has antihypertensive and antiarrhythmic pharmacological effects. It can exert anti-carcinogenic activity by regulating cell, inflammation, and apoptosis signaling pathways (Manogaran et al., 2019). However, its protective effect from sepsis-induced spleen damage is unknown. In this research, we established a mouse sepsis model induced by lipopolysaccharide (LPS) and investigated the protective effects of LIE on sepsis spleen injury in terms of inflammatory response, oxidative stress, and apoptosis.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"185-190"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260283/pdf/JZhejiangUnivSciB-24-2-185.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9979139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization. 与听神经病变谱系障碍相关的AIFM1变异由于细胞凋亡诱导因子二聚化受损而导致细胞凋亡。
Pub Date : 2023-02-15 DOI: 10.1631/jzus.B2200081
Yue Qiu, Hongyang Wang, Huaye Pan, Jing Guan, Lei Yan, Mingjie Fan, Hui Zhou, Xuanhao Zhou, Kaiwen Wu, Zexiao Jia, Qianqian Zhuang, Zhaoying Lei, Mengyao Li, Xue Ding, Aifu Lin, Yong Fu, Dong Zhang, Qiuju Wang, Qingfeng Yan

Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function. ANSD represents up to 15% of individuals with hearing impairments. Through mutation screening, bioinformatic analysis and expression studies, we have previously identified several apoptosis-inducing factor (AIF) mitochondria-associated 1 (AIFM1) variants in ANSD families and in some other sporadic cases. Here, to elucidate the pathogenic mechanisms underlying each AIFM1 variant, we generated AIF-null cells using the clustered regularly interspersed short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system and constructed AIF-wild type (WT) and AIF-mutant (mut) (p.‍T260A, p.‍R422W, and p.‍R451Q) stable transfection cell lines. We then analyzed AIF structure, coenzyme-binding affinity, apoptosis, and other aspects. Results revealed that these variants resulted in impaired dimerization, compromising AIF function. The reduction reaction of AIF variants had proceeded slower than that of AIF-WT. The average levels of AIF dimerization in AIF variant cells were only 34.5%‍‒‍49.7% of that of AIF-WT cells, resulting in caspase-independent apoptosis. The average percentage of apoptotic cells in the variants was 12.3%‍‒‍17.9%, which was significantly higher than that (6.9%‍‒‍7.4%) in controls. However, nicotinamide adenine dinucleotide (NADH) treatment promoted the reduction of apoptosis by rescuing AIF dimerization in AIF variant cells. Our findings show that the impairment of AIF dimerization by AIFM1 variants causes apoptosis contributing to ANSD, and introduce NADH as a potential drug for ANSD treatment. Our results help elucidate the mechanisms of ANSD and may lead to the provision of novel therapies.

听神经病变谱系障碍(ANSD)是一种以内耳毛细胞和/或听神经功能异常为特征,但外耳毛细胞功能保留的各种感觉神经性耳聋病症。听力障碍患者占听力障碍患者的15%。通过突变筛选、生物信息学分析和表达研究,我们已经在ANSD家族和一些其他散发性病例中发现了几个凋亡诱导因子(AIF)线粒体相关1 (AIFM1)变异。在这里,为了阐明每个AIFM1变异的致病机制,我们使用聚集规律穿插的短重复序列(CRISPR)/CRISPR相关蛋白9 (Cas9)系统生成AIF-null细胞,并构建aif -野生型(WT)和aif -突变型(mut) (p.‍T260A, p.‍R422W和p.‍R451Q)稳定转染细胞系。然后我们分析了AIF的结构、辅酶结合亲和力、细胞凋亡等方面。结果显示,这些变异导致二聚化受损,损害AIF功能。AIF变异体的还原反应比AIF- wt进行得慢。AIF变异细胞中AIF二聚化的平均水平仅为AIF- wt细胞的34.5%‍-‍49.7%,导致不依赖caspase的细胞凋亡。变异中凋亡细胞的平均百分比为12.3%‍~‍17.9%,显著高于对照组(6.9%‍~‍7.4%)。然而,烟酰胺腺嘌呤二核苷酸(nictinamide adenine dinucleotide, NADH)处理通过挽救AIF二聚体来促进AIF变异细胞的凋亡减少。我们的研究结果表明,AIFM1变异体对AIF二聚化的损害导致细胞凋亡导致ANSD,并将NADH作为ANSD治疗的潜在药物。我们的研究结果有助于阐明ANSD的机制,并可能导致提供新的治疗方法。
{"title":"<i>AIFM1</i> variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization.","authors":"Yue Qiu,&nbsp;Hongyang Wang,&nbsp;Huaye Pan,&nbsp;Jing Guan,&nbsp;Lei Yan,&nbsp;Mingjie Fan,&nbsp;Hui Zhou,&nbsp;Xuanhao Zhou,&nbsp;Kaiwen Wu,&nbsp;Zexiao Jia,&nbsp;Qianqian Zhuang,&nbsp;Zhaoying Lei,&nbsp;Mengyao Li,&nbsp;Xue Ding,&nbsp;Aifu Lin,&nbsp;Yong Fu,&nbsp;Dong Zhang,&nbsp;Qiuju Wang,&nbsp;Qingfeng Yan","doi":"10.1631/jzus.B2200081","DOIUrl":"https://doi.org/10.1631/jzus.B2200081","url":null,"abstract":"<p><p>Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function. ANSD represents up to 15% of individuals with hearing impairments. Through mutation screening, bioinformatic analysis and expression studies, we have previously identified several apoptosis-inducing factor (AIF) mitochondria-associated 1 (<i>AIFM1</i>) variants in ANSD families and in some other sporadic cases. Here, to elucidate the pathogenic mechanisms underlying each <i>AIFM1</i> variant, we generated AIF-null cells using the clustered regularly interspersed short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system and constructed AIF-wild type (WT) and AIF-mutant (mut) (p.‍T260A, p.‍R422W, and p.‍R451Q) stable transfection cell lines. We then analyzed AIF structure, coenzyme-binding affinity, apoptosis, and other aspects. Results revealed that these variants resulted in impaired dimerization, compromising AIF function. The reduction reaction of AIF variants had proceeded slower than that of AIF-WT. The average levels of AIF dimerization in AIF variant cells were only 34.5%‍‒‍49.7% of that of AIF-WT cells, resulting in caspase-independent apoptosis. The average percentage of apoptotic cells in the variants was 12.3%‍‒‍17.9%, which was significantly higher than that (6.9%‍‒‍7.4%) in controls. However, nicotinamide adenine dinucleotide (NADH) treatment promoted the reduction of apoptosis by rescuing AIF dimerization in AIF variant cells. Our findings show that the impairment of AIF dimerization by <i>AIFM1</i> variants causes apoptosis contributing to ANSD, and introduce NADH as a potential drug for ANSD treatment. Our results help elucidate the mechanisms of ANSD and may lead to the provision of novel therapies.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"172-184"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260280/pdf/JZhejiangUnivSciB-24-2-172.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway. 间充质干细胞移植治疗的新视角:针对铁下垂途径。
Pub Date : 2023-02-15 DOI: 10.1631/jzus.B2200410
Yuzhu Xu, Pan Fan, Lei Liu, X U Xuanfei, Lele Zhang, Jiadong Wang, Yuao Tao, Xiaolong Li, Xi Li, Yuntao Wang

Ex vivo culture-amplified mesenchymal stem cells (MSCs) have been studied because of their capacity for healing tissue injury. MSC transplantation is a valid approach for promoting the repair of damaged tissues and replacement of lost cells or to safeguard surviving cells, but currently the efficiency of MSC transplantation is constrained by the extensive loss of MSCs during the short post-transplantation period. Hence, strategies to increase the efficacy of MSC treatment are urgently needed. Iron overload, reactive oxygen species deposition, and decreased antioxidant capacity suppress the proliferation and regeneration of MSCs, thereby hastening cell death. Notably, oxidative stress (OS) and deficient antioxidant defense induced by iron overload can result in ferroptosis. Ferroptosis may inhibit cell survival after MSC transplantation, thereby reducing clinical efficacy. In this review, we explore the role of ferroptosis in MSC performance. Given that little research has focused on ferroptosis in transplanted MSCs, further study is urgently needed to enhance the in vivo implantation, function, and duration of MSCs.

体外培养扩增的间充质干细胞(MSCs)因其具有愈合组织损伤的能力而受到广泛的研究。间充质干细胞移植是促进受损组织的修复和丢失细胞的替换或保护存活细胞的有效方法,但目前间充质干细胞移植的效率受到移植后短时间内间充质干细胞大量丢失的限制。因此,迫切需要提高骨髓间充质干细胞治疗疗效的策略。铁超载、活性氧沉积和抗氧化能力下降抑制间充质干细胞的增殖和再生,从而加速细胞死亡。值得注意的是,铁超载引起的氧化应激(OS)和抗氧化防御不足可导致铁下垂。上睑下垂可能会抑制间充质干细胞移植后的细胞存活,从而降低临床疗效。在这篇综述中,我们探讨了铁下垂在MSC性能中的作用。由于对移植MSCs中铁下垂的研究较少,因此迫切需要进一步的研究来增强MSCs的体内植入、功能和持续时间。
{"title":"Novel perspective in transplantation therapy of mesenchymal stem cells: targeting the ferroptosis pathway.","authors":"Yuzhu Xu,&nbsp;Pan Fan,&nbsp;Lei Liu,&nbsp;X U Xuanfei,&nbsp;Lele Zhang,&nbsp;Jiadong Wang,&nbsp;Yuao Tao,&nbsp;Xiaolong Li,&nbsp;Xi Li,&nbsp;Yuntao Wang","doi":"10.1631/jzus.B2200410","DOIUrl":"https://doi.org/10.1631/jzus.B2200410","url":null,"abstract":"<p><p>Ex vivo culture-amplified mesenchymal stem cells (MSCs) have been studied because of their capacity for healing tissue injury. MSC transplantation is a valid approach for promoting the repair of damaged tissues and replacement of lost cells or to safeguard surviving cells, but currently the efficiency of MSC transplantation is constrained by the extensive loss of MSCs during the short post-transplantation period. Hence, strategies to increase the efficacy of MSC treatment are urgently needed. Iron overload, reactive oxygen species deposition, and decreased antioxidant capacity suppress the proliferation and regeneration of MSCs, thereby hastening cell death. Notably, oxidative stress (OS) and deficient antioxidant defense induced by iron overload can result in ferroptosis. Ferroptosis may inhibit cell survival after MSC transplantation, thereby reducing clinical efficacy. In this review, we explore the role of ferroptosis in MSC performance. Given that little research has focused on ferroptosis in transplanted MSCs, further study is urgently needed to enhance the in vivo implantation, function, and duration of MSCs.</p>","PeriodicalId":17601,"journal":{"name":"Journal of Zhejiang University. Science. B","volume":"24 2","pages":"115-129"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260286/pdf/JZhejiangUnivSciB-24-2-115.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9677378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Zhejiang University. Science. B
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1